IL13 and airway hyperresponsiveness: Released following airway epithelial injury, it activates the ST2 receptor, induces the production of IL-4, IL-5, and IL-13 by Th2 cells, mast cells, and other cell types, drives eosinophilic inflammation and airway hyperresponsiveness, and is closely linked to asthma susceptibility.